Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial.

Friedman DM, Llanos C, Izmirly PM, Brock B, Byron J, Copel J, Cummiskey K, Dooley MA, Foley J, Graves C, Hendershott C, Kates R, Komissarova EV, Miller M, Paré E, Phoon CK, Prosen T, Reisner D, Ruderman E, Samuels P, Yu JK, Kim MY, Buyon JP.

Arthritis Rheum. 2010 Apr;62(4):1138-46. doi: 10.1002/art.27308.

2.

Association of the idiotype:antiidiotype antibody ratio with the efficacy of intravenous immunoglobulin treatment for the prevention of recurrent autoimmune-associated congenital heart block.

Routsias JG, Kyriakidis NC, Friedman DM, Llanos C, Clancy R, Moutsopoulos HM, Buyon J, Tzioufas AG.

Arthritis Rheum. 2011 Sep;63(9):2783-9. doi: 10.1002/art.30464.

3.

Failure of intravenous immunoglobulin to prevent congenital heart block: Findings of a multicenter, prospective, observational study.

Pisoni CN, Brucato A, Ruffatti A, Espinosa G, Cervera R, Belmonte-Serrano M, Sánchez-Román J, García-Hernández FG, Tincani A, Bertero MT, Doria A, Hughes GR, Khamashta MA.

Arthritis Rheum. 2010 Apr;62(4):1147-52. doi: 10.1002/art.27350.

4.

Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects.

Clancy RM, Buyon JP, Ikeda K, Nozawa K, Argyle DA, Friedman DM, Chan EK.

Arthritis Rheum. 2005 Oct;52(10):3079-86.

5.

Neonatal lupus: bedside to bench and back.

Buyon JP.

Scand J Rheumatol. 1996;25(5):271-6. Review.

PMID:
8921918
6.

Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry.

Buyon JP, Hiebert R, Copel J, Craft J, Friedman D, Katholi M, Lee LA, Provost TT, Reichlin M, Rider L, Rupel A, Saleeb S, Weston WL, Skovron ML.

J Am Coll Cardiol. 1998 Jun;31(7):1658-66.

7.

[Congenital heart block associated with maternal anti SSA/SSB antibodies :a report of four cases].

Ayed K, Gorgi Y, Sfar I, Khrouf M.

Pathol Biol (Paris). 2004 Apr;52(3):138-47. Review. French.

PMID:
15063933
8.

[Neonatal lupus syndrome: Literature review].

Morel N, Georgin-Lavialle S, Levesque K, Guettrot-Imbert G, Le Guern V, Le Bidois J, Bessières B, Brouzes C, Le Mercier D, Villain E, Maltret A, Costedoat-Chalumeau N.

Rev Med Interne. 2015 Mar;36(3):159-66. doi: 10.1016/j.revmed.2014.07.013. Epub 2014 Sep 17. Review. French.

PMID:
25240481
9.

Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block.

Tseng CE, Caldwell K, Feit S, Chan EK, Buyon JP.

J Rheumatol. 1996 May;23(5):925-32.

PMID:
8724310
10.

Congenital heart block in neonatal lupus: the pediatric cardiologist's perspective.

Friedman DM, Rupel A, Glickstein J, Buyon JP.

Indian J Pediatr. 2002 Jun;69(6):517-22. Review.

PMID:
12139139
11.

Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.

Martínez-Sánchez N, Pérez-Pinto S, Robles-Marhuenda Á, Arnalich-Fernández F, Martín Cameán M, Hueso Zalvide E, Bartha JL.

Immunol Res. 2017 Jan 30. doi: 10.1007/s12026-016-8888-5. [Epub ahead of print]

PMID:
28138914
13.

Antenatal and postnatal combined therapy for autoantibody-related congenital atrioventricular block.

Di Mauro A, Caroli Casavola V, Favia Guarnieri G, Calderoni G, Cicinelli E, Laforgia N.

BMC Pregnancy Childbirth. 2013 Nov 29;13:220. doi: 10.1186/1471-2393-13-220.

14.

Significantly increased maternal and fetal IgG autoantibody levels to 52 kD Ro (SS-A) and La(SS-B) in complete congenital heart block.

Dörner T, Chaoui R, Feist E, Göldner B, Yamamoto K, Hiepe F.

J Autoimmun. 1995 Oct;8(5):675-84.

PMID:
8579723
15.

Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study.

Friedman DM, Kim MY, Copel JA, Davis C, Phoon CK, Glickstein JS, Buyon JP; PRIDE Investigators..

Circulation. 2008 Jan 29;117(4):485-93. doi: 10.1161/CIRCULATIONAHA.107.707661. Epub 2008 Jan 14.

16.

Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block.

Mevorach D, Elchalal U, Rein AJ.

Curr Opin Rheumatol. 2009 Sep;21(5):478-82. doi: 10.1097/BOR.0b013e32832ed817. Review.

PMID:
19584727
17.

Preventing congenital neonatal heart block in offspring of mothers with anti-SSA/Ro and SSB/La antibodies: a review of published literature and registered clinical trials.

Gleicher N, Elkayam U.

Autoimmun Rev. 2013 Sep;12(11):1039-45. doi: 10.1016/j.autrev.2013.04.006. Epub 2013 May 15. Review.

PMID:
23684701
18.

Description of 214 cases of autoimmune congenital heart block: Results of the French neonatal lupus syndrome.

Levesque K, Morel N, Maltret A, Baron G, Masseau A, Orquevaux P, Piette JC, Barriere F, Le Bidois J, Fermont L, Fain O, Theulin A, Sassolas F, Pezard P, Amoura Z, Guettrot-Imbert G, Le Mercier D, Georgin-Lavialle S, Deligny C, Hachulla E, Mouthon L, Ravaud P, Villain E, Bonnet D, Costedoat-Chalumeau N; “Lupus néonatal” group.; Group of collaborators..

Autoimmun Rev. 2015 Dec;14(12):1154-60. doi: 10.1016/j.autrev.2015.08.005. Epub 2015 Aug 15. Review.

PMID:
26284740
19.

Plasmapheresis, intravenous immunoglobulins and bethametasone - a combined protocol to treat autoimmune congenital heart block: a prospective cohort study.

Ruffatti A, Cerutti A, Favaro M, Del Ross T, Calligaro A, Hoxha A, Marson P, Leoni L, Milanesi O.

Clin Exp Rheumatol. 2016 Jul-Aug;34(4):706-13. Epub 2016 Jun 22.

PMID:
27385463
20.

A serologic marker for fetal risk of congenital heart block.

Salomonsson S, Dörner T, Theander E, Bremme K, Larsson P, Wahren-Herlenius M.

Arthritis Rheum. 2002 May;46(5):1233-41.

Supplemental Content

Support Center